Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Exosomes & Single Cell Analysis Summit

Steven Pirie-Shepherd's Biography



Steven Pirie-Shepherd, Director, Pfizer

Steven Pirie-Shepherd earned his PhD at Edinburgh University and completed postdoctoral work at Duke University and Brandeis University. He then trained in angiogenesis research with Judah Folkman at Harvard University. He transitioning to Industry, where he has been for the last 17 years, engaged in oncology drug discovery and development. For the last 7 years he has been occupied mostly with translational oncology and Biomarker research.

Steven Pirie-Shepherd Image

CTCs as Exploratory Biomarkers in Early Clinical Trials

Friday, 19 September 2014 at 17:45

Add to Calendar ▼2014-09-19 17:45:002014-09-19 18:45:00Europe/LondonCTCs as Exploratory Biomarkers in Early Clinical TrialsExosomes and Single Cell Analysis Summit in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

  • How do we define, collect, enumerate and characterize CTCs in early clinical trials?
  • What is Pharma looking for in the ‘perfect’ CTC assay platform?
  • What are the challenges in developing and deploying these assays in clinical trials?
  • What are we hoping to achieve with these assays?


Add to Calendar ▼2014-09-18 00:00:002014-09-19 00:00:00Europe/LondonExosomes and Single Cell Analysis SummitExosomes and Single Cell Analysis Summit in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com